Myotherix
WebMyotherix VentureRadar profile. Find out more about Myotherix, Small Molecule Pharmaceuticals. WebGiles Campion works at Myotherix, which is a Business Services company. Giles is currently based in Union City, California. Found email listings in clude: @myotherix.com. Read More. Contact. Giles Campion's Phone Number and Email. Last Update. 9/4/2024 11:09 AM. Email. g***@myotherix.com. Engage via Email.
Myotherix
Did you know?
WebMyoTherix, Inc. is a clinical stage, biopharmaceutical company that focuses on the development of innovative therapies for patients who are suffering from Duchenne … WebMYOTHERIX, INC. Street Address 1 Street Address 2; 1900 Powell Street, 6th Floor: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; Emeryville: CALIFORNIA: 94608: 857-222-4653: 3. Related Persons. Last Name First Name Middle Name; de Souza: Mark: P: Street Address 1 Street Address 2; c/o Myotherix, Inc.
WebMyoTherix is a clinical-stage drug discovery and development company for patients suffering from rare neuromuscular disorders. WebThe company was incorporated in 2013 and is based in Union City, California. digitGaps report on MYOTHERIX Inc delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and company operations by examining its performance in local market and global economy. digitGaps …
WebJun 21, 2024 · Anti-Inflammatory Therapy Anti-Fibrosis Therapy Mitochondrial Cardiac Function Muscle Regeneration Muscle Stabilization Cell Therapy * Discontinued means Discontinued at the clinical stage Last Updated 6/21/2024 Share This Page Make an Impact You can advance the care, treatment and cure for Duchenne muscular dystrophy. WebMyoTherix is a clinical-stage drug discovery and development company for patients suffering from rare neuromuscular disorders. Search Crunchbase Start Free Trial
WebSep 1, 2015 · NEWPORT BEACH, Calif., September 1, 2015 – CureDuchenne Ventures LLC, a company that funds research to find a cure for Duchenne muscular dystrophy, announced …
WebMyoTherix General Information. Description. Developer of innovative therapeutics intended to be used for the treatment of muscle disorders. The company utilizes an innovative and … tab ligabueWebSep 1, 2015 · “MyoTherix’s lead research program intends to improve both cardiac and skeletal muscle function, as well as reduce inflammation and facilitate new muscle regeneration,” said John Kincaid, co-Founder of MyoTherix Inc. “We are pleased to work with the team at CureDuchenne and look forward to developing this new approach to the … brazil training kit 2022WebSep 1, 2015 · $1 million in MyoTherix Inc., a biotechnology company focused on developing novel therapeutics for the treatment of Duchenne and other muscular dystrophies. The funds will support the Company’s ... brazil training topWebInc. Myotherix has a registered in the System for Award Management for doing business with and bidding for contracts by the United States government. Cage Code 72CN4 was listed as their unique company identifier. The company registered with SAM on 2013-12-04 and the registration with the below details. Company Details brazil translateWebPhone Number 857-222-4653. MyoTherix is a clinical-stage drug discovery and development company for patients suffering from rare neuromuscular disorders. It is a venture … tab librium 25WebJun 18, 2024 · He is a Co-Founder and also serves as Executive Chairman at FlightPath Biosciences. He also co-founded and served as Chairman and Chief Operating Officer at MyoTherix. He served as Executive Chairman more Contact Information Primary Investor Type Angel (individual) Primary Office 2600 Tenth Street Suite 435 Berkeley, CA 94710 … tabligh maksudWebMyoTherix is a drug discovery and development company focusing on therapies for patients suffering from Charcot Marie Tooth disease, Duchenne muscular dystrophy, and other … tablilla st5